Back to Trailblazers Hub


New guide for regional decision-makers in Spain aims to support delivery of heart failure care

HFPN collaborated with leading experts in Spain to develop a three-step framework to support the transformation of heart failure service in line with the Spanish National Cardiovascular Health Strategy.

Read More
Meet our members: Yvan Devaux

We spoke to HFPN member Yvan Devaux, Head of the Cardiovascular Research Unit at the Luxembourg Institute of Health.

Read More
Meet our members: Spyridon Gerovasileiou

We spoke to HFPN member Spyridon Gerovasileiou, Senior Consultant Cardiologist and Heart Failure Lead, Heart Failure Centre, Enköping Hospital; PhD Candidate in Cardiovascular Sciences, Uppsala University, Sweden.

Read More
Meet our members: Tiny Jaarsma

We spoke to HFPN member Tiny Jaarsma, Professor in Nursing at Linköping University, Sweden; and part-time Professor in Cardiovascular Nursing at University Medical Centre Utrecht, the Netherlands.

Read More
Meet our members: Damien Gruson

We spoke to HFPN member Prof Damien Gruson, Head of the Department of Laboratory Medicine, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Read More
Meet our members: Matthew Kahn

We spoke to Dr Matthew Kahn, Consultant Cardiologist (Heart Failure & Complex Devices), Cheshire & Merseyside Network Lead for Heart Failure & Device Therapy, Liverpool Heart and Chest Hospital, UK.

Read More
Meet our members: Ekaterini Lambrinou

We spoke to HFPN member Ekaterini Lambrinou, a Professor of Nursing at Cyprus University of Technology.

Read More
Meet our members: Marc Bains

We speak to HFPN member Marc Bains, Co-Founder of the HeartLife Foundation, Canada.

Read More
European Union Council Conclusions pave the way for progress in heart failure

On 3 December, the Council of the EU approved conclusions on cardiovascular health, marking a significant step toward improving outcomes in Europe. This milestone publication delivers long-awaited political commitment to address the burden of cardiovascular disease (CVD).

Read More
Event urges inclusion of heart failure in a European Cardiovascular Health Plan

The Hungarian Society of Cardiology Working Group on Heart Failure and Myocardial Diseases, with support from the HFPN, hosted an event to launch a policy submission on opportunities to reduce the burden of heart failure in Europe.

Read More
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Roche Diagnostics, Bayer and Netherlands Heart Institute. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership.